193 related articles for article (PubMed ID: 34262144)
1. CDK15 promotes colorectal cancer progression via phosphorylating PAK4 and regulating β-catenin/ MEK-ERK signaling pathway.
Huang C; Du R; Jia X; Liu K; Qiao Y; Wu Q; Yao N; Yang L; Zhou L; Liu X; Xiang P; Xin M; Wang Y; Chen X; Kim DJ; Dong Z; Li X
Cell Death Differ; 2022 Jan; 29(1):14-27. PubMed ID: 34262144
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signaling.
Tabusa H; Brooks T; Massey AJ
Mol Cancer Res; 2013 Feb; 11(2):109-21. PubMed ID: 23233484
[TBL] [Abstract][Full Text] [Related]
3. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
4. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway.
Zeng B; Shi W; Tan G
BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764
[TBL] [Abstract][Full Text] [Related]
5. MiR-199a/b-3p suppresses migration and invasion of breast cancer cells by downregulating PAK4/MEK/ERK signaling pathway.
Li SQ; Wang ZH; Mi XG; Liu L; Tan Y
IUBMB Life; 2015 Oct; 67(10):768-77. PubMed ID: 26399456
[TBL] [Abstract][Full Text] [Related]
6. PAK4, a target of miR-9-5p, promotes cell proliferation and inhibits apoptosis in colorectal cancer.
Wang M; Gao Q; Chen Y; Li Z; Yue L; Cao Y
Cell Mol Biol Lett; 2019; 24():58. PubMed ID: 31728150
[TBL] [Abstract][Full Text] [Related]
7. Group II p21-activated kinase, PAK4, is needed for activation of focal adhesion kinases, MAPK, GSK3, and β-catenin in rat pancreatic acinar cells.
Ramos-Álvarez I; Lee L; Jensen RT
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G490-G503. PubMed ID: 31984786
[TBL] [Abstract][Full Text] [Related]
8. Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma.
Lu SX; Zhang CZ; Luo RZ; Wang CH; Liu LL; Fu J; Zhang L; Wang H; Xie D; Yun JP
Cancer Lett; 2017 Aug; 402():71-80. PubMed ID: 28577975
[TBL] [Abstract][Full Text] [Related]
9. MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway.
Sheng N; Tan G; You W; Chen H; Gong J; Chen D; Zhang H; Wang Z
Cancer Med; 2017 Jun; 6(6):1331-1340. PubMed ID: 28440035
[TBL] [Abstract][Full Text] [Related]
10. p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
Yun CY; You ST; Kim JH; Chung JH; Han SB; Shin EY; Kim EG
J Invest Dermatol; 2015 May; 135(5):1385-1394. PubMed ID: 25560280
[TBL] [Abstract][Full Text] [Related]
11. The EIF3H-HAX1 axis increases RAF-MEK-ERK signaling activity to promote colorectal cancer progression.
Jin H; Huang X; Pan Q; Ma N; Xie X; Wei Y; Yu F; Wen W; Zhang B; Zhang P; Chen X; Wang J; Liu RY; Lin J; Meng X; Lee MH
Nat Commun; 2024 Mar; 15(1):2551. PubMed ID: 38514606
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
Peng K; Su G; Ji J; Yang X; Miao M; Mo P; Li M; Xu J; Li W; Yu C
J Biol Chem; 2018 Jul; 293(27):10606-10619. PubMed ID: 29802196
[TBL] [Abstract][Full Text] [Related]
13. p21-Activated kinase 3 promotes cancer stem cell phenotypes through activating the Akt-GSK3β-β-catenin signaling pathway in pancreatic cancer cells.
Wu HY; Yang MC; Ding LY; Chen CS; Chu PC
Cancer Lett; 2019 Aug; 456():13-22. PubMed ID: 31051214
[TBL] [Abstract][Full Text] [Related]
14. Nucleo-cytoplasmic shuttling of PAK4 modulates β-catenin intracellular translocation and signaling.
Li Y; Shao Y; Tong Y; Shen T; Zhang J; Li Y; Gu H; Li F
Biochim Biophys Acta; 2012 Feb; 1823(2):465-75. PubMed ID: 22173096
[TBL] [Abstract][Full Text] [Related]
15. LCH-7749944, a novel and potent p21-activated kinase 4 inhibitor, suppresses proliferation and invasion in human gastric cancer cells.
Zhang J; Wang J; Guo Q; Wang Y; Zhou Y; Peng H; Cheng M; Zhao D; Li F
Cancer Lett; 2012 Apr; 317(1):24-32. PubMed ID: 22085492
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
[TBL] [Abstract][Full Text] [Related]
17. p21-activated kinase 4 regulates ovarian cancer cell proliferation, migration, and invasion and contributes to poor prognosis in patients.
Siu MK; Chan HY; Kong DS; Wong ES; Wong OG; Ngan HY; Tam KF; Zhang H; Li Z; Chan QK; Tsao SW; Strömblad S; Cheung AN
Proc Natl Acad Sci U S A; 2010 Oct; 107(43):18622-7. PubMed ID: 20926745
[TBL] [Abstract][Full Text] [Related]
18. Activated-PAK4 predicts worse prognosis in breast cancer and promotes tumorigenesis through activation of PI3K/AKT signaling.
He LF; Xu HW; Chen M; Xian ZR; Wen XF; Chen MN; Du CW; Huang WH; Wu JD; Zhang GJ
Oncotarget; 2017 Mar; 8(11):17573-17585. PubMed ID: 28407679
[TBL] [Abstract][Full Text] [Related]
19. DNMT3A facilitates colorectal cancer progression via regulating DAB2IP mediated MEK/ERK activation.
Zhou Y; Yang Z; Zhang H; Li H; Zhang M; Wang H; Zhang M; Qiu P; Zhang R; Liu J
Biochim Biophys Acta Mol Basis Dis; 2022 Apr; 1868(4):166353. PubMed ID: 35063646
[TBL] [Abstract][Full Text] [Related]
20. PB-10, a thiazolo[4,5-d] pyrimidine derivative, targets p21-activated kinase 4 in human colorectal cancer cells.
Li R; Wang H; Wang J; Cheng M
Bioorg Med Chem Lett; 2020 Jan; 30(2):126807. PubMed ID: 31740249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
